- Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
- Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
- Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
- Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
- Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
- Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
More ▼
Key statistics
As of last trade, Astria Therapeutics Inc (ATXS:NMQ) traded at 9.01, 111.38% above the 52 week low of 4.26 set on Nov 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.03 |
---|---|
High | 9.14 |
Low | 8.95 |
Bid | 8.99 |
Offer | 9.02 |
Previous close | 9.02 |
Average volume | 436.73k |
---|---|
Shares outstanding | 54.91m |
Free float | 48.16m |
P/E (TTM) | -- |
Market cap | 495.32m USD |
EPS (TTM) | -2.32 USD |
Data delayed at least 15 minutes, as of May 24 2024 17:02 BST.
More ▼